Streetbeat News

Products Services

AZN

OCEA

Ocean Biomedical has published findings demonstrating its ability to restore treatment sensitivity to AstraZeneca's Tagrisso after resistance has formed, and improved tumor suppression in EGFR-Mutation Lung Cancers.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:04 pm

MAIA

MAIA Biotechnology has announced that the FDA has cleared its Investigational New Drug (IND) application for THIO, a first-in-class telomere targeting agent for treating non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:03 pm

GALT

Galectin Therapeutics, Inc. (NASDAQ:GALT) reported a positive outcome from its fourth data and safety monitoring board (DSMB) meeting for NAVIGATE, a Phase 2b/3 study of belapectin in patients with portal hypertension caused by non-alcoholic steatohepatitis (NASH) liver cirrhosis. The study is a global effort that randomized 357 patients in 14 countries. Interim topline data from the Phase 2b portion of NAVIGATE is expected in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:03 pm

BLKB

Blackbaud has announced the development of a new product, Impact Edge, which is designed for social impact reporting and storytelling. The product aims to help organizations measure and communicate their social impact effectively.

Portfolio Pulse from Bill Haddad

October 03, 2023 | 12:02 pm

VIR

Vir Biotechnology, Inc. (NASDAQ:VIR) has been awarded approximately $50 million in new funding by the Biomedical Advanced Research and Development Authority (BARDA) to advance the development of novel monoclonal antibody candidates and delivery solutions for COVID-19 and pandemic preparedness and response.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:01 pm

DIS

NFLX

Disney+ is tightening its subscription sharing rules, prohibiting sharing outside of one's household unless permitted by the service tier. This is part of Disney's strategy to monetize account sharing. Disney+ is also launching an ad-supported plan in Canada, the U.K., and eight European countries. Furthermore, Disney is increasing the prices of its premium subscription tiers in the U.S. The company is also exploring strategic partnerships for ESPN and plans to double its capital expenditures at its Disney Parks, Experiences, and Products segment.

Portfolio Pulse from Anusuya Lahiri

October 03, 2023 | 11:55 am

PPBT

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) has reported positive interim and preliminary results from its Phase 1/2 study of NT219, a first-in-class dual inhibitor of IRS 1/2 and STAT3. The company is planning the next clinical development steps with NT219 for second-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head & neck.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:51 am

PATH

UiPath (NYSE:PATH), an enterprise automation software company, has announced an enhanced partnership with Apprio, a provider of technology and service solutions for hospitals and health systems. The partnership aims to bring managed automation services to midmarket healthcare organizations, leveraging Apprio's capabilities in automating critical revenue cycle management functions.

Portfolio Pulse from Charles Gross

October 03, 2023 | 11:49 am

BBIO

BridgeBio Pharma and National Resilience have partnered to manufacture and advance BBP-812, a gene therapy for Canavan disease, and BBP-631, a gene therapy for congenital adrenal hyperplasia. The collaboration aims to accelerate the development of these therapies.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:36 am

SPRC

SciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company, has been granted a new patent by The European Patent Office. The patent, titled 'Combinations of Cannabinoids and N-Acylethanolamines', aligns with the company's objective to increase the safety of cannabinoids treatments while maintaining their therapeutic effects. The company has also been granted this patent in the United States, Japan, and Australia.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:34 am